ADS Position Statements/Guidelines - GDM/Obesity/Feet

Resources for Diabetes Health Professionals 

Gestational Diabetes Mellitus

A Position Statement on Gestational Diabetes in Australia

The Gestational Diabetes in Australia Position Statement has been developed by Diabetes Australia in collaboration with the Australian Diabetes Society, the Australian Diabetes Diabetes Educators Association and the Australasian Diabetes in Pregnancy Society to inform women who may be at risk of, or who develop, gestational diabetes mellitus (GDM) and also to inform the community, policy makers and health care providers. It is not intended as a clinical guidance document for health professionals. This Position Statement addresses the diagnosis, management and post-pregnancy care of women who develop GDM. It provides an overview of key issues relating to GDM and its impact and makes recommendations about the care and support women should receive.  There are three main types of diabetes affecting women in pregnancy: 

1. pre-existing type 1 diabetes 

2. pre-existing type 2 diabetes 

3. gestational diabetes (GDM) which is first detected during pregnancy and is different to type 1 diabetes or type 2 diabetes 

This Position Statement only addresses GDM, people with diabetes should always consult a health care professional before making decisions about their diabetes care.

Download the Gestational Diabetes in Australia Position Statement (Posted: August, 2020)


Obesity

Australian Obesity Management Algorithm

Summary
Obesity is a complex and multi-factorial chronic disease with genetic, environmental, physiological and behavioural determinants that requires long-term care. In 2014-15, 63.4% of Australians aged 18 years and over were above normal weight, with 27.9% being obese. Obesity is associated with a broad range of complications including type 2 diabetes, cardiovascular disease, dyslipidaemia, sleep apnoea, osteoarthritis, and certain types of cancers, which significantly impair quality of life. Obesity and its related complications place a considerable financial burden on Australia. In 2014-15, the direct and indirect costs of obesity were estimated at $ 8.65 billion.

This statement has been developed by a working group with representatives from the Australian Diabetes Society, the Australian and New Zealand Obesity Society and the Obesity Surgery Society of Australian and New Zealand.

The aims of the document are to:

1) Assist general practitioners (GPs) in treatment decisions for non-pregnant adults with obesity

2) Provide a practical clinical tool to guide the implementation of existing guidelines for the treatment of obesity in the primary care setting in Australia.

Download the full version of the Australian Obesity Management Algorithm - PDF (Posted: October, 2016)


Diabetes and Feet

2021 Evidenced-Based Australian Guidelines for Diabetes-Related Foot Disease

Following on from the release of the 2021 Australian guidelines for diabetes-related foot disease, we are excited to release the Diabetes and Feet companion toolkit that has been designed to help busy multidisciplinary health professionals use guideline recommended diabetes-related foot care at any time and place and with the person with diabetes-related foot ulcer right there in front of them. This resource was funded by the National Diabetes Services Scheme (NDSS), an initiative of the Australian Government and administered by Diabetes Australia, in partnership with Diabetes Feet Australia and the Australian Diabetes Society.

The Diabetes and Feet toolkit includes: • an overview of each guideline from the 2021 Australian guidelines for diabetes-related foot disease • recommendations for each guideline • implementation and monitoring considerations • considerations for the Australian context • practical pathways for each guideline to help optimise the implementation of the recommendations.

The toolkit and pathways should assist health professionals to decide on the recommended evidence-based assessment, diagnosis, management and follow-up care needed for people living with diabetes-related foot disease and diabetes-related foot ulcers. When more detailed information on a clinical question or a recommendation is required, we suggest you then refer to the full guidelines below. 

You can do this by quickly browsing the contents of each guideline, identifying the question you are most interested in and then read the recommendations made, the reasons why those recommendations were made and considerations on how to implement the recommendation in practice.

Please visit the Diabetes Feet Australia (DFA) website to access the 2021 Evidenced-Based Australian Guidelines for Diabetes-Related Foot Disease New Guidelines - Diabetes Feet Australia (Posted: April, 2022)

Please visit the National Diabetes Services Scheme (NDSS) website to access the Diabetes and Feet Toolkit Diabetes and feet: a practical toolkit for health professionals using the Australian diabetes-related foot disease guidelines (ndss.com.au) (Posted: April, 2022)